Needham & Company Starts SurModics (SRDX) at Buy
Tweet Send to a Friend
Needham & Company initiates coverage on SurModics (NASDAQ: SRDX) with a Buy rating and a price target of $42.00.Analyst Mike ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE